A pill that lowers cholesterol and is taken by thousands of Britons has been linked to an increased risk of cancer.
Drug safety chiefs in the U.S. are investigating a report of possible higher cancer rates among patients taking Inegy, a pill combining two kinds of medication.
The Food and Drug Administration said that it is reviewing data from a trial which found a 'larger percentage' of patients treated with the drug developed and died of cancer than those taking dummy medication.
Full data from the five-year trial of heart patients will be available to the FDA in three months' time and it is expected to issue its conclusions within six months.